Notice of Knight Therapeutics’ Third Quarter 2026 Results Conference Call
Financial Post ·
MONTREAL, Oct. 29, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-US) pharmaceutical company, will release its third quarter 2026 financial results on Thursday, November 5, 2026 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate […]
About Knight Therapeutics Inc. Read More